Freenome Pancreatic Cancer Data Preview Freenome's Plans for Expanded Cancer Detection Assay Premium The company shared new results from a pilot study training its platform to detect pancreatic cancers, showing high sensitivity in stage II to stage III tumors. Freenome Maintains CRC Early Detection Timeline as New Biomarker Discovery Studies Progress Premium The company is using newly raised funds to support a disseminated trial model, which it said will help it keep its plans to finish the study by the end of 2021. Freenome Closes $270M Series C Financing to Support Early Cancer Detection Trial The company said proceeds will accelerate the ongoing FDA registrational study of its blood-based colorectal cancer screening test and further its extended pipeline. People in the News: John Henderson, Daniel Spiegelman, Eric Schaefer, More Freenome Begins Prospective Study of Noninvasive Colorectal Cancer Screening Test Premium The company enters a race to the clinic with several direct competitors, including Guardant Health and CellMax Life, as well as other firms pursuing multi-cancer screening. Feb 5, 2020 Methylation, Fragmentation Analyses Remain at Forefront of Early Detection Liquid Biopsy Development Premium Aug 29, 2019 Freenome Expands Into Biomarker Discovery While Maintaining Early Detection Goals Premium Aug 26, 2019 Freenome, ADC Therapeutics Sign Biomarker Development Deal Jul 24, 2019 Freenome Closes $160M Series B Financing Round Apr 1, 2019 Guardant Health AACR Data Hint at Future Potential of Bellwether Acquisition Premium Oct 9, 2018 Freenome Shares New cfDNA Data, Building Evidence for Colorectal Cancer Blood Test Premium Jun 28, 2018 Freenome, Medical University of Graz Partner on Cancer Biomarker Research Breaking News IndyGeneUS AI Acquires Genetic Cryptocurrency Creator EncrypGen Analysis Estimates Psychiatric Disorder Risk from Specific Copy Number Variants in Danish Cohort Proteomic Profiling With Two Platforms Provides Complementary Gene, Protein, Phenotype Links Centogene Reports 17 Percent Drop in Q3 Revenues, Closing Down COVID Testing Business StageZero Raising C$4.2M in Private Placement of Stocks, Warrants NGeneBio Gets CE-IVD Mark for HLA Typing Assay The Scan Comfort of Home The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity. Keep Under Control Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says. Just Make It The New York Times writes that there is increased interest in applying gene synthesis to even more applications. Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.